Department of Liver Surgery & Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, People's Republic of China.
Department of Pancreatic Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, People's Republic of China.
HPB (Oxford). 2019 May;21(5):531-538. doi: 10.1016/j.hpb.2018.09.009. Epub 2018 Oct 19.
Few studies have analyzed the impact of liver cirrhosis on different hepatic inflow occlusion methods in laparoscopic liver resection (LLR). Intermittent Pringle (IP) was compared to continuous hemihepatic vascular inflow occlusion (CHVIO) in LLR in patients with or without cirrhosis.
Patients who underwent LLR at the West China Hospital of Sichuan University form January 2015 to October 2017 were grouped according to occlusion methods and severity of cirrhosis. A matched propensity score analysis was performed.
Among patients without cirrhosis, there were no significant differences in blood loss (238 ± 30 ml VS 265 ± 46 ml, P = 0.653), operative time (228 ± 9 min VS 265 ± 20 min, P = 0.437) or other postoperative results between the IP and CHVIO groups after propensity score matching. Among patients with cirrhosis, blood loss (279 ± 24 ml VS 396 ± 35 ml, P = 0.012) and operative time (237 ± 11 min VS 285 ± 24 min, P = 0.041) were significantly lower in the IP group, while postoperative liver function did not significantly differ between the two groups after propensity score matching.
In patients without cirrhosis, IP is as efficient and as safe as CHVIO in cirrhotic patients. IP offers the advantages of shorter operative time and less blood loss and does not result in worse postoperative liver function.
很少有研究分析肝硬化对腹腔镜肝切除(LLR)中不同肝血流阻断方法的影响。在伴有或不伴有肝硬化的患者中,与间歇阻断肝门(IP)相比,连续半肝入肝血流阻断(CHVIO)在 LLR 中的应用。
根据阻断方法和肝硬化严重程度,将 2015 年 1 月至 2017 年 10 月在四川大学华西医院行 LLR 的患者分为两组。采用倾向性评分匹配分析。
在无肝硬化患者中,IP 组与 CHVIO 组在出血量(238±30ml 比 265±46ml,P=0.653)、手术时间(228±9min 比 265±20min,P=0.437)或其他术后结果方面均无显著差异。在肝硬化患者中,IP 组的出血量(279±24ml 比 396±35ml,P=0.012)和手术时间(237±11min 比 285±24min,P=0.041)均显著降低,但术后肝功能无显著差异。
在无肝硬化患者中,IP 与 CHVIO 一样安全有效。IP 具有手术时间短、出血量少的优点,且不会导致术后肝功能恶化。